Immunotherapy & Vaccine Design Platform

About ImmunoMind

ImmunoMind is an AI-driven biotech startup building an open-source ecosystem for personalized immunotherapy and vaccine design. Its technology platform, rooted in the widely-used Immunarch bioinformatics tool, applies machine learning to single-cell and bulk multi-omics data to analyze immune cell populations, with a strong initial focus on improving CAR-T cell therapy development. The company targets biopharma partners, biotech startups, and research institutions, aiming to de-risk drug discovery, enhance clinical trial success, and fuel novel biomarker discovery. As a pre-revenue platform company, its growth is tied to strategic partnerships with major pharmaceutical and academic entities.

Therapeutic Areas